HIRSCH RUSSELL C

CIK 00011620594 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001162059

Recent Transactions

50 trades

Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+76,949→ 1,900,716 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−76,949→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−102,301→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−102,301→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−1,530,269→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+102,301→ 395,799 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+1,530,269→ 1,823,767 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+76,949→ 1,900,716 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−173,912→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+261,977→ 293,498 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+261,977→ 293,498 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+102,301→ 395,799 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+671,807→ 2,572,523 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−173,912→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−102,301→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−173,912→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−1,530,269→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−102,301→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−76,949→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−76,949→ 0 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+671,807→ 2,572,523 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+261,977→ 293,498 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+1,530,269→ 1,823,767 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+261,977→ 293,498 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+261,977→ 293,498 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+102,301→ 395,799 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+76,949→ 1,900,716 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−173,912→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−173,912→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−102,301→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+261,977→ 293,498 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−1,530,269→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−76,949→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−173,912→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−102,301→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+1,530,269→ 1,823,767 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+261,977→ 293,498 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−173,912→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+261,977→ 293,498 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+1,530,269→ 1,823,767 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+671,807→ 2,572,523 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−1,530,269→ 0 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+671,807→ 2,572,523 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+261,977→ 293,498 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−173,912→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+1,530,269→ 1,823,767 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+1,530,269→ 1,823,767 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−76,949→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−173,912→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−76,949→ 0 total

Companies

Recent Filings

4
Vitae Pharmaceuticals, Inc
Oct 1, 2014

Address

C/O PROSPECT VENTURE PARTNERS 435 TASSO STREET, SUITE 200

PALO ALTO, CA, 94301

View on SEC.gov